| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.49B | 41.66B | 43.91B | 43.49B | 44.20B | 38.91B |
| Gross Profit | 6.88B | 7.31B | 6.75B | 5.93B | 7.21B | 5.64B |
| EBITDA | 2.57B | 3.22B | 2.37B | 1.54B | 2.32B | 669.00M |
| Net Income | 634.00M | 1.50B | 1.16B | -598.00M | 508.00M | -1.13B |
Balance Sheet | ||||||
| Total Assets | 44.78B | 47.29B | 47.01B | 48.60B | 48.33B | 46.77B |
| Cash, Cash Equivalents and Short-Term Investments | 7.53B | 8.56B | 7.93B | 8.66B | 7.10B | 8.01B |
| Total Debt | 17.59B | 18.39B | 18.81B | 20.81B | 20.17B | 19.88B |
| Total Liabilities | 27.86B | 27.43B | 29.31B | 33.24B | 33.27B | 32.69B |
| Stockholders Equity | 16.91B | 19.86B | 17.70B | 15.36B | 15.04B | 14.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 441.00M | 603.00M | 723.00M | -792.00M | -4.74B |
| Operating Cash Flow | 0.00 | 1.61B | 2.79B | 2.93B | 1.16B | -2.72B |
| Investing Cash Flow | 0.00 | -683.00M | -495.00M | -2.05B | -1.76B | -1.24B |
| Financing Cash Flow | 0.00 | -413.00M | -2.44B | 295.00M | -593.00M | 3.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥281.69B | 7.78 | 8.91% | 3.85% | 5.98% | 39.06% | |
78 Outperform | ¥88.27B | 7.87 | ― | 3.82% | 3.17% | 654.02% | |
69 Neutral | ¥15.29B | 4.56 | ― | 3.41% | 1.98% | 150.85% | |
67 Neutral | ¥18.36B | 21.58 | ― | 1.17% | 24.89% | 26.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥11.97B | 10.62 | ― | 6.70% | -1.89% | -12.80% | |
58 Neutral | ¥6.59B | 2.15 | ― | 1.37% | -5.11% | 29.29% |